Katarzyna Guzik

Dr. Katarzyna Guzik

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2019 in Molecules
Verified
Journal Article
Open access
PDF file
KGKatarzyna Guzik
Katarzyna Guzik
MTMarcin Tomala
Marcin Tomala
DMDamian Muszak
Damian Muszak
MKMagdalena Konieczny
Magdalena Konieczny
AHAleksandra Hec
Aleksandra Hec
THTad Holak
Tad Holak
Cancer immunotherapy based on antibodies targeting the immune checkpoint PD-1/PD-L1 pathway has seen unprecedented clinical responses and constitutes the new paradigm in cancer therapy. The antibody-based immunotherapies have several limitations such as high production cost of the antibodies or their long half-life. Small-molecule inhibitors of the PD-1/PD-L1 interaction have been highly anticipated as a promising alternative or complementary therapeutic to the monoclonal antibodies (mAbs). Currently, the field of developing anti-PD-1/PD-L1 small-molecule inhibitors is intensively explored. In this paper, we review anti-PD-1/PD-L1 small-molecule and peptide-based inhibitors and discuss recent structural and preclinical/clinical aspects of their development. Discovery of the therapeutics based on small-molecule inhibitors of the PD-1/PD-L1 interaction represents a promising but challenging perspective in cancer treatment.

1 June 2021 in Bioelectrochemistry
Verified
Journal Article
Closed access
PNPawel Niedzialkowski
Pawel Niedzialkowski
MBMagdalena Bojko
Magdalena Bojko
Jacek RylJacek Ryl
Jacek Ryl
AWAnna Wcisło
Anna Wcisło
MSMarta Spodzieja
Marta Spodzieja
SRSylwia Rodziewicz-Motowidło
Sylwia Rodziewicz-Motowidło